Cargando…
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621358/ https://www.ncbi.nlm.nih.gov/pubmed/26550493 http://dx.doi.org/10.1155/2015/309042 |
_version_ | 1782397425651023872 |
---|---|
author | Omar, Mahmoud Abdel-Razek, Wael Abo-Raia, Gamal Assem, Medhat El-Azab, Gasser |
author_facet | Omar, Mahmoud Abdel-Razek, Wael Abo-Raia, Gamal Assem, Medhat El-Azab, Gasser |
author_sort | Omar, Mahmoud |
collection | PubMed |
description | Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candidates for living donor liver transplantation with serum creatinine (Cr) <1.5 mg/dL were included. CysC, Cr, and estimated GFR [creatinine clearance (CCr), Cockcroft-Gault formula (C-G), MDRD equations with 4 and 6 variables, CKD-EPI-Cr, CKD-EPI-CysC, and CKD-EPI-Cr-CysC] were all correlated to isotopic GFR. Early RI was defined as GFR of 60–89 mL/min/1.73 m(2). Results. Patients were 25.7% and 74.3% Child-Pugh classes B and C, respectively. GFR was ≥90, 60–89, and 30–59 mL/min/1.73 m(2) in 31.4%, 64.3%, and 4.3% of the patients, respectively. All markers and equations, except C-G, were significantly correlated to GFR with CKD-EPI-Cr-CysC formula having the highest correlation (r = 0.474) and the largest area under the ROC curve (0.808) for discriminating early RI. At a cutoff value of 1.2 mg/L, CysC was 89.6% sensitive and 63.6% specific in detecting early RI. Conclusion. In patients with liver cirrhosis, CysC and CysC-based equations showed the highest significant correlation to GFR and were measures that best discriminated early RI. |
format | Online Article Text |
id | pubmed-4621358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46213582015-11-08 Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis Omar, Mahmoud Abdel-Razek, Wael Abo-Raia, Gamal Assem, Medhat El-Azab, Gasser Int J Hepatol Research Article Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candidates for living donor liver transplantation with serum creatinine (Cr) <1.5 mg/dL were included. CysC, Cr, and estimated GFR [creatinine clearance (CCr), Cockcroft-Gault formula (C-G), MDRD equations with 4 and 6 variables, CKD-EPI-Cr, CKD-EPI-CysC, and CKD-EPI-Cr-CysC] were all correlated to isotopic GFR. Early RI was defined as GFR of 60–89 mL/min/1.73 m(2). Results. Patients were 25.7% and 74.3% Child-Pugh classes B and C, respectively. GFR was ≥90, 60–89, and 30–59 mL/min/1.73 m(2) in 31.4%, 64.3%, and 4.3% of the patients, respectively. All markers and equations, except C-G, were significantly correlated to GFR with CKD-EPI-Cr-CysC formula having the highest correlation (r = 0.474) and the largest area under the ROC curve (0.808) for discriminating early RI. At a cutoff value of 1.2 mg/L, CysC was 89.6% sensitive and 63.6% specific in detecting early RI. Conclusion. In patients with liver cirrhosis, CysC and CysC-based equations showed the highest significant correlation to GFR and were measures that best discriminated early RI. Hindawi Publishing Corporation 2015 2015-10-13 /pmc/articles/PMC4621358/ /pubmed/26550493 http://dx.doi.org/10.1155/2015/309042 Text en Copyright © 2015 Mahmoud Omar et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Omar, Mahmoud Abdel-Razek, Wael Abo-Raia, Gamal Assem, Medhat El-Azab, Gasser Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title | Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title_full | Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title_fullStr | Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title_full_unstemmed | Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title_short | Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis |
title_sort | evaluation of serum cystatin c as a marker of early renal impairment in patients with liver cirrhosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621358/ https://www.ncbi.nlm.nih.gov/pubmed/26550493 http://dx.doi.org/10.1155/2015/309042 |
work_keys_str_mv | AT omarmahmoud evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis AT abdelrazekwael evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis AT aboraiagamal evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis AT assemmedhat evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis AT elazabgasser evaluationofserumcystatincasamarkerofearlyrenalimpairmentinpatientswithlivercirrhosis |